Equity raised for exploration
Rights issue, placement and shareholder purchase plan increased year-end cash; the annual report also identified going-concern material uncertainty.
Five annual reports for Cullen Resources Limited, an exploration company. Amounts are Australian dollars unless marked cents/share or shares. The tables distinguish annual flows from 30 June balances and distinguish reported values from presentation differences.
Reading the tables: 0 (nil) is a supported zero. Other text distinguishes an amount included in another line, a non-applicable item, a separately unavailable component and an unresolved value. These are not interchangeable. Period-specific detail is labelled; complete year-by-year detail remains available.
Consolidated statutory loss for year ended 30 June 2025.
At 30 June 2025, before subsequent royalty proceeds.
Capitalised expenditure during the year.
A$4,538,190 at 30 June 2025.
Cullen remained focused on mineral exploration. Statutory losses and operating cash outflows persisted across the five years, while the cash balance fell markedly by June 2025. Equity issues funded exploration and group costs; A$60,000 of director loans appeared in FY2025. The group did not report mineral production or AISC as its operating basis.
The A$4,747,995 Mt Stuart deferred-consideration and royalty intangible stayed on the consolidated position statement. The auditor qualified its FY2025 opinion because it could not obtain sufficient evidence supporting the directors’ valuation assumptions; the FY2024 opinion had a similar qualification. A post-year-end Wyloo royalty sale brought A$1.5m after the 30 June 2025 balance date and is excluded from the closing cash table.
Rights issue, placement and shareholder purchase plan increased year-end cash; the annual report also identified going-concern material uncertainty.
Exploration spending exceeded A$1m and the reported loss widened. Partner interests across Australian projects and Finland were described in the annual report.
Wongan Hills drilling and the Finland farm-out featured in the year’s exploration activity. The loss narrowed, while operating cash remained negative.
The 30 June position had net current liabilities; an A$739,372 rights issue settled on 23 August 2024, after that balance date.
Cash was A$7,380 at 30 June. Directors advanced A$60,000 during the year; A$1.5m from the Wyloo royalty sale was received after year end.
Cullen’s reported statutory loss narrowed after FY2022. EPS also reflects a changing weighted-average share base, so its movement should not be read as a like-for-like loss change per fixed share count.
AUD
AI-generated presentation · values from Consolidated profit or loss (AUD); no missing values plotted as zero.
cents/share
AI-generated presentation · values from Earnings per share and weighted shares; no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 69,504 | 55,655 | 84,598 | 119,876 | 157,763 |
| Rent expense | (35,556) | (36,095) | (35,469) | (36,847) | (35,663) |
| Salaries and consultants' fees | (177,381) | (171,242) | (168,318) | (223,032) | (226,920) |
| Compliance expenses | (132,373) | (91,356) | (85,998) | (90,612) | (96,478) |
| Share based payments | (118,800) | 0 (nil) | 0 (nil) | (51,840) | 0 |
| Impairment of exploration expenditure | (874,706) | (1,054,147) | (828,588) | (754,115) | (600,771) |
| Depreciation | (1,769) | (12,653) | (12,651) | (10,947) | (319) |
| Other expenses | (75,570) | (69,526) | (119,644) | (93,869) | (99,935) |
| Loss before income tax | (1,346,651) | (1,379,364) | (1,166,070) | (1,141,386) | (902,321) |
| Income tax expense/(benefit) | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) | 0 |
| Net loss attributable to members after tax | (1,346,651) | (1,379,364) | (1,166,070) | (1,141,386) | (902,321) |
| Other comprehensive income | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) |
| Total comprehensive income/(loss) for the period | (1,346,651) | (1,379,364) | (1,166,070) | (1,141,386) | (902,321) |
Expense and loss rows retain their reported negative signs. FY2025 revenue includes interest and disposal-related income; it is not mineral production revenue.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
mixed
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Basic (loss) per sharecents/share | (0.44) | (0.35) | (0.25) | (0.21) | (0.13) |
| Diluted (loss) per sharecents/share | (0.44) | (0.35) | (0.25) | (0.21) | (0.13) |
| Weighted average ordinary shares (basic and diluted)shares | 308,746,910 | 390,884,630 | 467,899,579 | 543,712,297 | 675,170,766 |
Basic and diluted EPS are reported values. Weighted average shares are an EPS denominator, not the closing share register.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
Cash declined through the later years. FY2025 total assets include the unchanged A$4.75m Mt Stuart intangible, whose valuation was subject to the auditor qualification. Director loans were A$60,000 at 30 June 2025.
AUD
AI-generated presentation · values from Consolidated financial position at 30 June (AUD); no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 1,413,662 | 594,563 | 588,109 | 91,931 | 7,380 |
| Receivables | 41,274 | 7,121 | 15,080 | 12,751 | 38,624 |
| Total Current Assets | 1,454,936 | 601,684 | 603,189 | 104,682 | 46,004 |
| Plant & equipment | 4,665 | 23,917 | 11,266 | 319 | 0 (nil) |
| Exploration & evaluation | 14,162 | 8,760 | 34,615 | 12,397 | 29,575 |
| Intangible assets | 4,747,995 | 4,747,995 | 4,747,995 | 4,747,995 | 4,747,995 |
| Total Non-Current Assets | 4,766,822 | 4,780,672 | 4,793,876 | 4,760,711 | 4,777,570 |
| Total Assets | 6,221,758 | 5,382,356 | 5,397,065 | 4,865,393 | 4,823,574 |
| Trade and other payables | 62,826 | 31,873 | 36,013 | 21,902 | 73,916 |
| Borrowings (current) | not separately presented | not separately presented | not separately presented | 0 | 60,000 |
| Provisions (current) | 101,498 | 112,413 | 130,367 | 142,352 | 151,468 |
| Total Current Liabilities | 164,324 | 144,286 | 166,380 | 164,254 | 285,384 |
| Total Liabilities | 164,324 | 144,286 | 166,380 | 164,254 | 285,384 |
| Net Assets | 6,057,434 | 5,238,070 | 5,230,685 | 4,701,139 | 4,538,190 |
FY2025 component and total rows recovered from the selected original consolidated statement of financial position. A dash for FY2025 plant and equipment means nil carrying amount.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
Exploration payments dominate investing outflows. The FY2022 original statement and its FY2023 comparative place a A$50,000 reimbursement in different cash-flow categories; the table retains the contemporaneous FY2022 statement and flags that boundary.
AUD
AI-generated presentation · values from Consolidated cash flows (AUD); no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net operating cash outflows | (351,088) | (303,904) | (387,513) | (438,649) | (383,531) |
| Payments for exploration and evaluation | (865,793) | (1,048,745) | (854,443) | (731,897) | (617,949) |
| Payment for plant and equipment | (6,434) | (31,905) | 0 (nil) | not separately presented | not separately presented |
| Proceeds from sale of plant and equipment | 0 (nil) | 5,455 | 0 (nil) | not separately presented | not separately presented |
| Exploration proceeds/reimbursement (FY2022 operating; FY2023–FY2025 investing) | not separately presented | 50,000 | 76,817 | 114,368 | 117,557 |
| Net investing cash outflows | (872,227) | (1,075,195) | (777,626) | (617,529) | (500,392) |
| Proceeds from issue of shares | 2,454,742 | 560,000 | 1,169,185 | 560,000 | 739,372 |
| Proceeds from borrowings | not separately presented | not separately presented | not separately presented | 0 (nil) | 60,000 |
| Net financing cash inflows | 2,365,942 | 560,000 | 1,158,685 | 560,000 | 799,372 |
| Net (decrease)/increase in cash | 1,142,627 | (819,099) | (6,454) | (496,178) | (84,551) |
| Cash and cash equivalents at start of year | 271,035 | 1,413,662 | 594,563 | 588,109 | 91,931 |
| Cash and cash equivalents at end of year | 1,413,662 | 594,563 | 588,109 | 91,931 | 7,380 |
FY2022 uses its original cash-flow-statement classification: A$50,000 exploration reimbursement appears in operating activities. FY2023 comparative reclassified that amount to investing, producing a A$50,000 lower operating subtotal. Do not compare those FY2022 classifications as if identical.
Exploration and plant payments are cash movements, not year-end asset carrying values.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating (loss) after income tax | (1,346,651) | (1,379,364) | (1,166,070) | (1,141,386) | (902,321) |
| Impairment of exploration | 874,706 | 1,054,147 | 828,588 | 754,115 | 600,771 |
| Share based payments | 118,800 | 0 (nil) | not separately presented | 51,840 | 0 (nil) |
| Depreciation | 1,769 | 12,653 | 12,651 | 10,947 | 319 |
| Change in provisions for employee benefits | 18,352 | 10,915 | 17,954 | 11,985 | 9,116 |
| Change in trade and other payables | (16,866) | (30,953) | 4,140 | (14,111) | 52,014 |
| Change in receivables | (1,198) | 34,153 | (7,959) | 2,329 | (25,873) |
| Less: profit on sale of plant and equipment | 0 (nil) | (5,455) | 0 (nil) | not separately presented | not separately presented |
| Less: profit on sale of exploration interest | not separately presented | not separately presented | (76,817) | (114,368) | (117,557) |
| Net operating cashflows (subtotal) | (351,088) | (303,904) | (387,513) | (438,649) | (383,531) |
The FY2022 subtotal follows the contemporaneous FY2022 reconciliation. Its A$50,000 exploration reimbursement was operating cash and no exploration-interest sale-profit deduction was shown there; the FY2023 comparative moved that amount to investing and added a A$50,000 deduction. The FY2022 column retains the original basis.
Profit deductions remove disposal gains from operating cash reconciliation. They are distinct from the cash proceeds shown in the consolidated cash-flow table.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
Funding came primarily from ordinary-share issues. FY2025 closing issued capital and equity are directly supported by the original statement; the contributed-equity movement confirms 693,401,849 ordinary shares at 30 June 2025. The report-date register is a later snapshot and is not the basis of this balance-date count.
AUD
AI-generated presentation · values from Closing total equity and accumulated losses (AUD); no missing values plotted as zero.
mixed
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Issued capital (A$, closing balance)AUD | 48,299,395 | 48,859,395 | 50,018,080 | 50,578,080 | 51,317,452 |
| Ordinary shares on issue (number)shares | 373,917,657 | 406,858,855 | 504,290,902 | 570,173,234 | 693,401,849 |
FY2025 issued capital comes from the original position statement. FY2025 693,401,849 closing ordinary shares come from the same annual report's Note 12 contributed-equity movement; the 26 September 2025 shareholder-register date is not used as the balance-date basis.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total equity (A$, closing) | 6,057,434 | 5,238,070 | 5,230,685 | 4,701,139 | 4,538,190 |
| Accumulated losses (A$, closing, negative) | (42,369,852) | (43,740,125) | (44,906,195) | (45,928,781) | (46,831,102) |
Balance-sheet stocks at each 30 June, not cash flows.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
shares
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Unissued shares under option (year-end) | 18,454,545 | 18,000,000 | 18,000,000 | 18,000,000 | 18,000,000 |
FY2023 source claim is at report date rather than explicitly 30 June; its FY2024 comparative confirms 18,000,000 at FY2023 year end.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
AUD/share
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Dividend recommended | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) | None recommended |
The FY2025 Directors' Report explicitly recommends no dividend for the current financial year and states that none has been declared or paid since the previous year end. This is a direct statement, not an inference from earlier years.
Source: Cullen directors’ annual statements in FY2021–FY2024 packets.
Cullen capitalised exploration activity and separately recognised write-offs. These are not production costs. The FY2025 exploration asset closed at A$29,575 after A$617,949 incurred and A$600,771 impaired.
AUD
AI-generated presentation · values from Exploration and evaluation asset movement (AUD); no missing values plotted as zero.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Opening balance | 23,075 | 14,162 | 8,760 | 34,615 | 12,397 |
| Expenditure incurred during the year | 865,793 | 1,048,745 | 854,443 | 731,897 | 617,949 |
| Write-off / impairment (negative) | (874,706) | (1,054,147) | (828,588) | (754,115) | (600,771) |
| Closing balance net of write-off | 14,162 | 8,760 | 34,615 | 12,397 | 29,575 |
Expenditure incurred/capitalised is a flow. Closing exploration and evaluation is an asset balance after write-offs. FY2024–FY2025 flows are issuer narrative or statutory impairment lines; closing balances are position-statement rows.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Carrying amount at beginning | 0 (nil) | 4,665 | 23,917 | 11,266 | 319 |
| Additions | 6,434 | 31,905 | 0 (nil) | 0 (nil) | 0 (nil) |
| Depreciation expense (negative) | (1,769) | (12,653) | (12,651) | (10,947) | (319) |
| Closing carrying amount | 4,665 | 23,917 | 11,266 | 319 | 0 (nil) |
The table reports carrying amounts and depreciation. Investing cash payments for plant are not used as opening or closing asset values.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
AUD
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Minimum exploration expenditure commitment (next year) | 450,500 | 673,500 | 600,500 | 590,000 | 310,000 |
Each figure is the obligation over the next year from the relevant reporting date; it is not current-year exploration spend.
Source: Cullen annual reports FY2021–FY2025; exact records and selected table rows are in author/evidence.json.
Prepared from the existing annual extraction datasets, supplemented only by selected same-company annual-report tables and saved row interpretations. No new raw-document extraction or web financial research was used for this test.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.